Abstract
The DA strain and other members of the TO subgroup of Theiler's murine encephalomyelitis virus (TMEV) induce a chronic demyelinating disease with a restricted virus expression. This disease serves as an experimental model of multiple sclerosis; in both diseases the immune system contributes to a similar demyelinating pathology. Like all picornaviruses, TMEV encodes a polyprotein translated from one long open reading frame. The polyprotein is then processed into structural and non–structural viral proteins. Here, we demonstrate that the DA strain of TMEV has an additional alternative open reading frame that encodes a protein called L* that is present in infected cells. Virus with a mutation of L* has a dramatically decreased demyelinating activity, indicating that L* plays a critical role in TO subgroup–induced demyelinating disease. L* is associated with membranes, suggesting that L* may interact with the immune system and thereby mediate the viral–induced demyelinating disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Roos, R.P. & Casteel, N. Determinants of neurological disease induced by Theiler's murine encephalomyelitis virus. in Molecular Neurovirology (ed Roos, R.P.) 283–318 (Humana Press, Totowa, New Jersey, 1992).
Kaminski, A., Belsham, G.J. & Jackson, R.J. Translation of encephalomyocarditis virus RNA: Parameters influencing the selection of the internal initiation site. EMBO J. 13, 1673–1681 (1994).
Wimmer, E., Hellen, C.U.T. & Cao, X. Genetics of poliovirus. Annu. Rev. Genet. 27, 353–436 (1993).
Kaminski, A., Howell, M.T. & Jackson, R.J. Initiation of encephalomyocarditis virus RNA translation: The authentic initiation site is not selected by a scanning mechanism. EMBO J. 9, 3753–3759 (1990).
Sangar, D.V., Newton, S.E., Rowlands, D.J. & Clarke, B.E. All foot and mouth disease virus serotypes initiate protein synthesis at two separate AUGs. Nucleic Acids Res. 15, 3305–3315 (1987).
Tesar, M., Harmon, S.A., Summers, D.F. & Ehrenfeld, E. Hepatitis A virus polyprotein synthesis initiates from two alternative AUG codons. Virology 186, 609–618 (1992).
Kong, W.-P. & Roos, R.P. Alternative translation initiation site in the DA strain of Theiler's murine encephalomyelitis virus. J. Virol. 65, 3395–3399 (1991).
Celma, M.L. & Ehrenfeld, E. Translation of poliovirus RNA in vitro: Detection of two different initiation sites. J. molec. Biol. 65, 3395–3399 (1975).
Dorner, A.J. et al. In vitro translation of poliovirus RNA: Utilization of internal initiation sites in reticulocyte lysate. J. Virol. 50, 507–514 (1984).
Phillips, B.A. & Emmert, A. Modulation of the expression of poliovirus proteins in reticulocyte lysate. Virology 148, 255–267 (1986).
Nunez, R. & Lynch, R.G. CD23 isoforms in murine T and B lymphocytes. Pathobiology 61, 128–137 (1993).
Gordon, J. B-cell signalling via the C-type lectins CD23 and CD72. Immim. Today 15, 411–417 (1994).
Baines, J.D., Ward, P.L., Campadelli-Fiume, G. & Roizman, B. The UI20 gene of herpes simplex virus 1 encodes a function necessary for viral egress. J. Virol. 65, 6414–6424 (1991).
Spear, P.G. & Roizman, B. Proteins specified by herpes simplex viruses. I. Identification of four glycoprotein precursors and their products in type I-in-fected cells. J. Virol. 9, 143–159 (1972).
Fu, J. et al. Neurovirulence determinants of genetically engineered Theiler viruses. Proc. natn. Acad. Sci. U.S.A. 87, 4125–4129 (1990).
Pritchard, A.E., Calenoff, M.A., Simpson, S., Jensen, K. & Lipton, H.L. A single base deletion in the 5′ noncoding region of Theiler's virus attenuates neurovirulence. J. Virol. 66, 1951–1958 (1992).
Zhang, L., Sato, S., Kim, J.I. & Roos, R.P. Theiler's virus as a vector for foreign gene delivery. J. Virol. 69, 3171–3175 (1995).
Zurbriggen, A., Thomas, C., Yamada, M., Roos, R.P. & Fujinami, R.S. Direct evidence of a role for amino acid 101 of VP-1 in central nervous system disease in Theiler's murine encephalomyelitis virus infection. J. Virol. 65, 1929–1937 (1991).
Roos, R.P. et al. Theiler's murine encephalomyelitis virus neutralization escape mutants have a change in disease phenotype. J. Virol. 63, 4469–4473 (1989).
Jarousse, N. et al. A single amino acid change determines persistence of a chimeric Theiler's virus. J. Virol. 68, 3364–3368 (1994).
Rodriguez, M. & Roos, R.P. Pathogenesis of early and late disease in mice infected with Theiler's virus, using intratypic recombinant GDVII/DA viruses. J. Virol. 66, 217–225 (1992).
Patick, A.K., Oleszak, E.L., Leibowitz, J.L. & Rodriguez, M. Persistent infection of a glioma cell line generates a Theiler's virus variant which fails to induce de-myelinating disease in SJL/J mice. J. gen. Virol. 71, 2123–2132 (1990).
Oleszak, E.L., Leibowitz, J.L. & Rodriguez, M. Isolation and characterization of two plaque size variants of Theiler's murine encephalomyelitis virus (DA strain). J. gen. Virol. 69, 2413–2418 (1988).
Clatch, R.J., Lipton, H.L. & Miller, S.D. Characterization of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed type hypersensitivity responses in TMEV-induced demyelinating disease: Correlation with clinical signs. J. Immun. 136, 920–927 (1986).
Fujinami, R.S., Zurbriggen, A. & Powell, H.C. Monoclonal antibody defines a determinant between Theiler's virus and lipid-like structure. J. Neuroimmun. 20, 25–32 (1988).
Imataka, H. et al. Cell-specific translational control of transcription factor BTEB expression. J. biol. Chem. 269, 20668–20673 (1994).
Hill, J.R. & Morris, D.R. Cell-specific translational regulation of S-adenosylme-thionine decarboxylase mRNA. Dependence on translation and coding capacity of the cis-acting upstream open reading frame. J. biol. Chem. 267, 21886–21893 (1992).
Roos, R.P., Kong, W.-P. & Semler, B.L. Polyprotein processing of Theiler's murine encephalomyelitis virus. J. Virol. 63, 5344–5353 (1989).
Roos, R.P., Stein, S., Ohara, Y., Fu, J. & Semler, B.L. Infectious cDNA clones of the DA strain of Theiler's murine encephalomyelitis virus. J. Virol. 63, 5492–5496 (1989).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chen, HH., Kong, WP., Zhang, L. et al. A picornaviral protein synthesized out of frame with the polyprotein plays a key role in a virus–induced immune–mediated demyelinating disease. Nat Med 1, 927–931 (1995). https://doi.org/10.1038/nm0995-927
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nm0995-927
This article is cited by
-
Characterization of Plaque-Sized Variants of Daniel’s (DA) Strain in Theiler’s Virus-Induced Epilepsy
Scientific Reports (2019)
-
A novel cardiovirus in wild rats
Virology Journal (2018)
-
Host genetic background influences diverse neurological responses to viral infection in mice
Scientific Reports (2017)
-
Viral security proteins: counteracting host defences
Nature Reviews Microbiology (2010)
-
LIM domain only 4 protein promotes granulocyte colony-stimulating factor-induced signaling in neurons
Cellular and Molecular Life Sciences (2010)